Nanjing Hicin Pharmaceutical Co (SZSE:300584) Other Long Term Assets : ¥194.7 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Nanjing Hicin Pharmaceutical Co Other Long Term Assets?

Nanjing Hicin Pharmaceutical Co's other long-term assets for the quarter that ended in Mar. 2025 was ¥194.7 Mil.

Nanjing Hicin Pharmaceutical Co's quarterly other long-term assets declined from Sep. 2024 (¥210.9 Mil) to Dec. 2024 (¥192.3 Mil) but then increased from Dec. 2024 (¥192.3 Mil) to Mar. 2025 (¥194.7 Mil).

Nanjing Hicin Pharmaceutical Co's annual other long-term assets declined from Dec. 2022 (¥238.7 Mil) to Dec. 2023 (¥216.5 Mil) and declined from Dec. 2023 (¥216.5 Mil) to Dec. 2024 (¥192.3 Mil).

Nanjing Hicin Pharmaceutical Co Other Long Term Assets Historical Data

The historical data trend for Nanjing Hicin Pharmaceutical Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Hicin Pharmaceutical Co Other Long Term Assets Chart

Nanjing Hicin Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

157.24

456.38

238.70

216.51

192.26

Nanjing Hicin Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long Term Assets	Get a 7-Day Free Trial															209.49	214.80	210.93	192.26	194.70

Nanjing Hicin Pharmaceutical Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Nanjing Hicin Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing Hicin Pharmaceutical Co Ltd (SZSE:300584) » Definitions » Other Long Term Assets

Traded in Other Exchanges

N/A

Address

Heng Road 1, Nanjing Economic and Technological Development Zone, Jiangsu Province, Nanjing, CHN, 210009

Website

http://www.hicin.cn

Nanjing Hicin Pharmaceutical Co Ltd is a China-based company engaged in producing pharmaceutical preparations. In addition, it is also involved in manufacturing synthetic chemicals, conducting new drug research and development as well as technical transferring. The company produces series of the medicines such as antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for the cardio-cerebral system and immuno-modulate agents. The active pharmaceutical ingredients, omeprazole sodium for injection, cefepime hydrochloride for Injection and lansoprazole tablets are exported by the firm into South-Asian countries, South-American countries and European countries.

Executives

Cao Yu Ping	Directors, executives
Yan Mei Qiang	Directors, executives
Jiang Xiang Ming	Executives
Gu Hai	Independent director

Nanjing Hicin Pharmaceutical Co Headlines

No Headlines